ZyVersa director Robert Finizio resigns from board effective Dec 2, 2025

ZyVersa Therapeutics, Inc.

Independent director Robert G. Finizio resigned as board member, Compensation Committee chair, and Audit Committee member.
Resignation effective immediately on December 2, 2025; accepted by the Board.
Resignation was for personal reasons, not due to any disagreement with the Company on operations, policies, or practices.
No replacement has been announced for the vacated board or committee positions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.